Screener Summaries Updates Institutions Sign In More Updates › Other Events › AMIX Other Events · Jul 10, 2026
Autonomix Medical, Inc. received a letter from Nasdaq notifying the company's common stock has regained compliance… AMIX Autonomix Medical, Inc.
Autonomix Medical, Inc. received a letter from Nasdaq notifying the company's common stock has regained compliance with the Bid Price Rule after the closing bid price remained at or above $1.00 per share for 10 consecutive business days from June 24, 2026, through July 8, 2026. Autonomix Medical, Inc. operates in the medical technology industry and develops diagnostic tools for gastrointestinal health.
More from Autonomix Medical, Inc. Stockholders approve $750K share increase to the 2023 Stock Plan and grant reverse split authority Nov 3, 2026 Autonomix Medical, Inc. expanded its Board of Directors from five to six members by appointing Sandra Kalter as an… Sep 16, 2026 On August 24, 2026, Autonomix Medical entered into a warrant inducement agreement requiring the holder of existing… Aug 26, 2026 On July 13, 2026, Autonomix Medical, Inc. entered into a warrant inducement agreement with a holder of Series C… Jul 15, 2026 Autonomix Medical, Inc. has announced a 1-for-21 reverse stock split of its common stock, effective June 24, 2026 Jun 24, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
